Evidence map›Paper›PMID 30717650›Full record

ArticleBMC bioinformatics2019

GlyStruct: glycation prediction using structural properties of amino acid residues.

Hamendra Manhar Reddy, Alok Sharma, Abdollah Dehzangi, Daichi Shigemizu, Abel Avitesh Chandra, Tatushiko Tsunoda

Abstract read
In one paragraph

Article in BMC bioinformatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hamendra Manhar ReddySchool of Engineering & Physics, University of the South Pacific, Suva, Fiji. hamendra.reddy@gmail.com.ORCID http://orcid.org/0000-0003-4852-3778
Alok SharmaSchool of Engineering & Physics, University of the South Pacific, Suva, Fiji. alok.sharma@griffith.edu.au.
Abdollah DehzangiDepartment of Computer Science, Morgan State University, Baltimore, MD, USA.
Daichi ShigemizuLaboratory for Medical Science Mathematics, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.
Abel Avitesh ChandraSchool of Engineering & Physics, University of the South Pacific, Suva, Fiji.
Tatushiko TsunodaLaboratory for Medical Science Mathematics, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.

Funding

The University of the South Pacific FST14/F3205
6 · The paper itself

Abstract

backgroundGlycation is a one of the post-translational modifications (PTM) where sugar molecules and residues in protein sequences are covalently bonded. It has become one of the clinically important PTM in recent times attributed to many chronic and age related complications. Being a non-enzymatic reaction, it is a great challenge when it comes to its prediction due to the lack of significant bias in the sequence motifs.

resultsWe developed a classifier, GlyStruct based on support vector machine, to predict glycated and non-glycated lysine residues using structural properties of amino acid residues. The features used were secondary structure, accessible surface area and the local backbone torsion angles. For this work, a benchmark dataset was extracted containing 235 glycated and 303 non-glycated lysine residues. GlyStruct demonstrated improved performance of approximately 10% in comparison to benchmark method of Gly-PseAAC. The performance for GlyStruct on the metrics, sensitivity, specificity, accuracy and Mathew's correlation coefficient were 0.7013, 0.7989, 0.7562, and 0.5065, respectively for 10-fold cross-validation.

conclusionGlycation has emerged to be one of the clinically important PTM of proteins in recent times. Therefore, the development of computational tools become necessary to predict glycation, which could help medical professionals administer drugs and manage patients more effectively. The proposed predictor manages to classify glycated and non-glycated lysine residues with promising results consistently on various cross-validation schemes and outperforms other state of the art methods.

Indexed as

AlgorithmsAmino AcidsAmino Acid SequenceArea Under CurveBenchmarkingComputational BiologyGlycosylationHumansPeptidesSupport Vector MachineAmino AcidsPeptidesAmino acidsLysine glycationPost-translational modificationPredictionProtein sequencesSupport vector machine

Identifiers

PMID30717650
PMCPMC7394324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.